Standout Papers
Citation Impact
Citing Papers
Does the Evidence Support the Use of Mycophenolate Mofetil Therapeutic Drug Monitoring in Clinical Practice? A Systematic Review
2008
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
Stem Cell–Derived Culture Models of Hepatitis E Virus Infection
2018 StandoutNobel
Regulatory T cells in autoimmune kidney diseases and transplantation
2023 StandoutNobel
Graft microvascular disease in solid organ transplantation
2014 StandoutNobel
Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants
2017
mTOR inhibitors effects on regulatory T cells and on dendritic cells
2016
Post-Transplant Anti-HLA Class II Antibodies as Risk Factor for Late Kidney Allograft Failure
2006
Low pre-transplant adiponectin multimers are associated with adverse allograft outcomes in kidney transplant recipients a 3-year prospective study
2012
Pan-Genotype Hepatitis E Virus Replication in Stem Cell–Derived Hepatocellular Systems
2017 StandoutNobel
Role of P-glycoprotein in cyclosporine cytotoxicity in the cyclosporine–sirolimus interaction
2006
Response of human renal tubular cells to cyclosporine and sirolimus: A toxicogenomic study
2008
Ischemia and reperfusion—from mechanism to translation
2011 Standout
The use of a DNA biobank linked to electronic medical records to characterize pharmacogenomic predictors of tacrolimus dose requirement in kidney transplant recipients
2011
Acute kidney injury
2012 Standout
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
Suicide and Suicidal Behavior
2008 Standout
No Difference in Degree of Interstitial Sirius Red–Stained Area in Serial Biopsies from Area under Concentration-over-Time Curves–Guided Cyclosporine versus Tacrolimus-Treated Renal Transplant Recipients at One Year
2005
The Utility of 1- and 3-Month Protocol Biopsies on Renal Allograft Function: A Randomized Controlled Study
2008
Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data
2005
Low serum magnesium is associated with decreased graft survival in patients with chronic cyclosporin nephrotoxicity
2005
Conversion From Calcineurin Inhibitors to Sirolimus Maintenance Therapy in Renal Allograft Recipients: 24-Month Efficacy and Safety Results From the CONVERT Trial
2009
Renal ultrasound elastography
2013
Renocortical mRNA expression of vasoactive factors during spironolactone protective effect in chronic cyclosporine nephrotoxicity
2005
Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation
2010 Standout
Stem Cell Therapies in Clinical Trials: Progress and Challenges
2015 Standout
Cellular senescence in aging and age-related disease: from mechanisms to therapy
2015 Standout
Rejection of the Kidney Allograft
2010
Evidence for Antibody-Mediated Injury as a Major Determinant of Late Kidney Allograft Failure
2010
Vascular access modifies the protective effect of obesity on survival in hemodialysis patients
2015
Calcineurin inhibitor‐sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity
2007
Risk Factors for Early Epithelial to Mesenchymal Transition in Renal Grafts
2006
CYP3A5 and CYP3A4 but not MDR1 Single-nucleotide Polymorphisms Determine Long-term Tacrolimus Disposition and Drug-related Nephrotoxicity in Renal Recipients
2007
Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival
2013 Standout
Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus
2005
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
2017 Standout
Everolimus-based calcineurin-inhibitor sparing regimens for kidney transplant recipients: a systematic review and meta-analysis
2014
The Generation of Donor-Specific CD4+CD25++CD45RA+ Naive Regulatory T Cells in Operationally Tolerant Patients After Pediatric Living-Donor Liver Transplantation
2010 StandoutNobel
Minimizing Immunosuppression, an Alternative Approach to Reducing Side Effects
2008
Factors influencing glomerular filtration rate in renal transplantation after cyclosporine withdrawal using sirolimus‐based therapy: a multivariate analysis of results at five years1
2007
YSPSL (rPSGL‐Ig) for improvement of early renal allograft function: a double‐blind, placebo‐controlled, multi‐center Phase IIa study1,2,3
2010
Three‐Year Efficacy and Safety Results from a Study of Everolimus Versus Mycophenolate Mofetil in de novo Renal Transplant Patients
2005
Effector Mechanisms of Rejection
2013
New insights into the pathophysiology of cyclosporine nephrotoxicity: a role of aldosterone
2007
Chronic kidney disease
2011 Standout
The Relationship Between Kidney Function and Long-term Graft Survival After Kidney Transplant
2011
ABCB1 Genotype of the Donor but Not of the Recipient Is a Major Risk Factor for Cyclosporine-Related Nephrotoxicity after Renal Transplantation
2005
A Novel, Semiquantitative, Clinically Correlated Calcineurin Inhibitor Toxicity Score for Renal Allograft Biopsies
2006
Early Epithelial Phenotypic Changes Predict Graft Fibrosis
2008
Oxidative stress as a common pathway to chronic tubulointerstitial injury in kidney allografts
2007
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Baseline Immunosuppression is Associated with Histological Findings in Early Protocol Biopsies
2004
Calcineurin Inhibitor Avoidance with Daclizumab, Mycophenolate Mofetil, and Prednisolone in DR-Matched de Novo Kidney Transplant Recipients
2006
Chronic Allograft Nephropathy: Current Concepts and Future Directions
2006
Variation in numbers of CD4+CD25highFOXP3+T cells with normal immuno-regulatory properties in long-term graft outcome
2007
Randomized Controlled Study Comparing Reduced Calcineurin Inhibitors Exposure Versus Standard Cyclosporine-Based Immunosuppression
2007
Rituximab is an effective treatment for lupus nephritis and allows a reduction in maintenance steroids
2009
One-Year Results with Extended-Release Tacrolimus/MMF, Tacrolimus/MMF and Cyclosporine/MMF in De Novo Kidney Transplant Recipients
2007
Prognostic associations of serum calcium, phosphate and calcium phosphate concentration product with outcomes in kidney transplant recipients
2006
Acute Tubular Injury in Protocol Biopsies of Renal Grafts: Prevalence, Associated Factors and Effect on Long-Term Function
2008
Diagnosis and prevention of chronic kidney allograft loss
2011
De Novo Kidney Transplantation Without Use of Calcineurin Inhibitors Preserves Renal Structure and Function at Two Years
2004
Cytochrome P450 3A5 expression in the kidneys of patients with calcineurin inhibitor nephrotoxicity
2007
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Molecular mechanisms of T cell co-stimulation and co-inhibition
2013 Standout
Myasthenia gravis
2019 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Tacrolimus Exposure and Evolution of Renal Allograft Histology in the First Year After Transplantation
2007
Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation
2007 Standout
Predicting Subsequent Decline in Kidney Allograft Function from Early Surveillance Biopsies
2005
Meta-Analysis of Biochemical and Patient-Level Effects of Calcimimetic Therapy
2006
A Phase III Study of Belatacept‐based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)
2010 Standout
The Significance of Subclinical Rejection and the Value of Protocol Biopsies
2006
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
2018 Standout
A primer on recurrent and de novo glomerulonephritis in renal allografts
2008
The Evolution of Nonimmune Histological Injury and Its Clinical Relevance in Adult-Sized Kidney Grafts in Pediatric Recipients
2007
Prednisone‐Free Maintenance Immunosuppression—A 5‐Year Experience
2005
Long-Term Outcomes of Pre-emptive Valganciclovir Compared with Valacyclovir Prophylaxis for Prevention of Cytomegalovirus in Renal Transplantation
2012
Management of Chronic Allograft Nephropathy
2009
Costimulation Blockade with Belatacept in Renal Transplantation
2005 Standout
Lupus nephritis: where are we now?
2010
Antibody-Mediated Microcirculation Injury Is the Major Cause of Late Kidney Transplant Failure
2009
Protocol Biopsies in Renal Transplantation: Insights into Patient Management and Pathogenesis
2007
Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath
2005
Can Donor Implantation Renal Biopsy Predict Long-Term Renal Allograft Outcome?
2007
Predictors of Renal Allograft Histologic Damage Progression
2005
Subclinical Acute Antibody-Mediated Rejection in Positive Crossmatch Renal Allografts
2007
Molecular Comparison of Calcineurin Inhibitor–Induced Fibrogenic Responses in Protocol Renal Transplant Biopsies
2006
Identifying Specific Causes of Kidney Allograft Loss
2009 Standout
Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats
2008
Calcineurin Inhibitor–Induced Nephrotoxicity and Renal Expression of P‐glycoprotein
2005
Comparison of Steroid Avoidance in Tacrolimus/Mycophenolate Mofetil and Tacrolimus/Sirolimus Combination in Kidney Transplantation Monitored by Surveillance Biopsy
2005
In vivo prevention of transplant arteriosclerosis by ex vivo–expanded human regulatory T cells
2010
Sirolimus Versus Cyclosporine in Kidney Recipients Receiving Thymoglobulin®, Mycophenolate Mofetil and a 6‐Month Course of Steroids
2007
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence
2011 Standout
Kidney Allograft Fibrosis and Atrophy Early After Living Donor Transplantation
2005
Opportunities for Treg cell therapy for the treatment of human disease
2023 StandoutNobel
Transplant Glomerulopathy, Late Antibody-Mediated Rejection and the ABCD Tetrad in Kidney Allograft Biopsies for Cause
2007
HLA-Mismatched Renal Transplantation without Maintenance Immunosuppression
2008 Standout
The therapeutic potential of carbon monoxide
2010 Standout
Immunotherapy in Elderly Transplant Recipients
2009
Risk Factors for Reaching Renal Endpoints in the Assessment of Lescol in Renal Transplantation (ALERT) Trial
2005
Conversion From Cyclosporine to Tacrolimus in Patients at Risk for Chronic Renal Allograft Failure: 60-Month Results of the CRAF Study
2008
Chronic Progressive Calcineurin Nephrotoxicity: An Overstated Concept
2011
Inflammation Lesions in Kidney Transplant Biopsies: Association with Survival Is Due to the Underlying Diseases
2011
Presence of FoxP3+ Regulatory T Cells Predicts Outcome of Subclinical Rejection of Renal Allografts
2008
Adipose Tissue as an Endocrine Organ
2004 Standout
Rational Development of LEA29Y (belatacept), a High-Affinity Variant of CTLA4-Ig with Potent Immunosuppressive Properties
2005
Lack of Benefit of Early Protocol Biopsies in Renal Transplant Patients Receiving TAC and MMF: A Randomized Study
2007
Calcineurin Inhibitors Stimulate and Mycophenolic Acid Inhibits Replication of Hepatitis E Virus
2014
Cellular senescence: from physiology to pathology
2014 Standout
Therapeutic Applications of Bilirubin and Biliverdin in Transplantation
2007
Intracellular calcium release channels: an update
2017
Mechanisms of Cell Protection by Heme Oxygenase-1
2010 Standout
Unique properties of thymic antigen-presenting cells promote epigenetic imprinting of alloantigen-specific regulatory T cells
2017 StandoutNobel
Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients
2014
CD4+T cells control the differentiation of Gr1+monocytes into fibrocytes
2009
Long-Term Renal Allograft Survival in the United States: A Critical Reappraisal
2010 Standout
Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis
2015 StandoutNobel
Clinical Significance of an Early Protocol Biopsy in Living-Donor Renal Transplantation: Ten-Year Experience at a Single Center
2005
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients
2014
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
The Clinical Benefits of Cyclosporine C2-Level Monitoring: A Systematic Review
2007
Expansion of CD45RA−FOXP3++ regulatory T cells is associated with immune tolerance in patients with combined kidney and bone marrow transplantation
2021
Control of foreign Ag‐specific Ab responses by Treg and Tfr
2020 StandoutNobel
Regulatory B cells: Development, phenotypes, functions, and role in transplantation
2019
Cellular Senescence Limits Regenerative Capacity and Allograft Survival
2012
Preformed Frequencies of Cytomegalovirus (CMV)–Specific Memory T and B Cells Identify Protected CMV-Sensitized Individuals Among Seronegative Kidney Transplant Recipients
2014
Case 12-2007
2007
Evolution and Clinical Pathologic Correlations of De Novo Donor-Specific HLA Antibody Post Kidney Transplant
2012 Standout
KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update
2020 Standout
Mechanisms of Renal Fibrosis
2017 Standout
The expanding family of regulatory B cells
2015
Ultrasound Elastography: Review of Techniques and Clinical Applications
2017 Standout
C4d-Positive Chronic Rejection: A Frequent Entity With a Poor Outcome
2007
[Suicide prevention for the elderly in Matsunoyama Town, Higashikubiki County, Niigata Prefecture: psychiatric care for elderly depression in the community].
1998
Works of Richard Borrows being referenced
Transitional B Lymphocytes Are Associated With Protection From Kidney Allograft Rejection: A Prospective Study
2015
The causes, significance and consequences of inflammatory fibrosis in kidney transplantation: The Banff i-IFTA lesion
2017
Evolution and Pathophysiology of Renal-Transplant Glomerulosclerosis
2004
Delta Analysis of Posttransplantation Tubulointerstitial Damage
2004
Calcineurin Inhibitor Sparing With Mycophenolate in Kidney Transplantation: A Systematic Review and Meta-Analysis
2009
Calcineurin Inhibitor Nephrotoxicity: Longitudinal Assessment by Protocol Histology
2004
Obesity in Kidney Transplantation
2013
Meta-Analysis of Calcineurin-Inhibitor-Sparing Regimens in Kidney Transplantation
2011
The Natural History of Chronic Allograft Nephropathy
2003 Standout
Identification of the Optimal Donor Quality Scoring System and Measure of Early Renal Function in Kidney Transplantation
2009
Steroid Sparing with Tacrolimus and Mycophenolate Mofetil in Renal Transplantation
2004
The Magnitude and Time Course of Changes in Mycophenolic Acid 12-Hour Predose Levels During Antibiotic Therapy in Mycophenolate Mofetil-Based Renal Transplantation
2007
Impaired Direct Priming of CD8 T Cells by Donor-Derived Cytomegalovirus Following Kidney Transplantation
2013
Mycophenolic Acid 12-h Trough Level Monitoring in Renal Transplantation: Association with Acute Rejection and Toxicity
2005
Natural History, Risk Factors, and Impact of Subclinical Rejection in Kidney Transplantation
2004
Determinants of Mycophenolic Acid Levels After Renal Transplantation
2005
Five Years of Steroid Sparing in Renal Transplantation with Tacrolimus and Mycophenolate Mofetil
2006
Comparison of the Predictive Performance of eGFR Formulae for Mortality and Graft Failure in Renal Transplant Recipients
2009